36C24219Q0299-000.docx
DOCX document 13 KB Posted
- Attached to
- Intent to Sole Source Siemens Chemistry & Immunochemistry Cost Per Reportable (CPRR) Testing
- Solicitation number
- 36C24219Q0299
About this file
36C24219Q0299 36C24219Q0299.docx
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
FedBizOpps Special Notice
CLASSIFICATION CODE
SUBJECT
CONTRACTING OFFICE'S
ZIP-CODE
SOLICITATION NUMBER
ARCHIVE
DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
NAICS CODE
CONTRACTING OFFICE
ADDRESS
POINT OF CONTACT
(POC Information Automatically Filled from User Profile Unless Entered)
DESCRIPTION
See Attachment
AGENCY'S URL
URL DESCRIPTION
AGENCY CONTACT'S EMAIL
ADDRESS
EMAIL DESCRIPTION
GENERAL INFORMATION
ADDITIONAL INFORMATION
* = Required Field FedBizOpps Special Notice Rev. March 2010 Q Intent to Sole Source Siemens Chemistry & Immunochemistry Cost Per Reportable (CPRR) Testing 10468-3904 36C24219Q0299 N 334516 Department of Veterans Affairs Network Contracting Office 2 James J. Peters VA Medical Center 130 West Kingsbridge Road Bronx NY 10468-3904 Paul Speedling paul.speedling@va.gov The Department of Veterans Affairs, James J. Peters Veterans Affairs Medical Center (VISN 2 Downstate), intends to award a short term, interim, sole-source, firm fixed price FSS Delivery Order (FSS-DO) to Siemens Healthcare Diagnostics, Inc., FSS Contract # V797D-30175, in accordance with FAR Subpart 8.405-6.
The FSS-DO will be effective April 1, 2019 through September 30, 2019. With an additional three-month option.
The acquisition sought is an interim FSS-DO that will cover 6 months of reagents, consumables, supplies needed to produce a cost-per-reportable result (CPRR) and for the continued usage of contractor-owned equipment currently on-site at VISN 2 Downstate Medical Centers.
VA personnel utilize the equipment and reagents to perform Chemistry/Special Chemistry including Drug of Abuse (DOA) and Therapeutic Drugs Monitoring (TDM) testing. The NAICS is 334516 with a small business size standard of 1,000 employees.
The current FSS-DO with Siemens Healthcare Diagnostics, Inc. will expire on March 31, 2019. This interim FSS-DO is required to continue to provide testing until the equipment included in the new, long-term FSS-BPA, which was awarded in 2018, is fully implemented and functional.
This notice of intent is not a request for competitive proposals and no solicitation will be made available.
Any responses received no later than COB February 13, 2019 will be considered for the purposes of determining sources for future procurements. The Government will not pay for information submitted. Any information submitted in response to this notice of intent is strictly voluntary.
This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement.
File details come from the government source that posted it.